Evidence map›Paper›PMID 31362739›Full record

ArticleBMC veterinary research2019

Platelet-rich plasma affects the proliferation of canine bone marrow-derived mesenchymal stromal cells in vitro.

Sony Pandey, Dawn U Hickey, Marti Drum, Darryl L Millis, Maria Cekanova

Abstract read
In one paragraph

Article in BMC veterinary research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sony PandeyDepartment of Small Animal Clinical Siences, College of Veterinary Medicine, The University of Tennessee, Knoxville, 37996, TN, USA.
Dawn U HickeyDepartment of Small Animal Clinical Siences, College of Veterinary Medicine, The University of Tennessee, Knoxville, 37996, TN, USA.
Marti DrumDepartment of Small Animal Clinical Siences, College of Veterinary Medicine, The University of Tennessee, Knoxville, 37996, TN, USA.
Darryl L MillisDepartment of Small Animal Clinical Siences, College of Veterinary Medicine, The University of Tennessee, Knoxville, 37996, TN, USA.
Maria CekanovaDepartment of Small Animal Clinical Siences, College of Veterinary Medicine, The University of Tennessee, Knoxville, 37996, TN, USA. mcekanov@utk.edu.ORCID http://orcid.org/0000-0002-9651-1619

Funding

University of Tennessee R181721-352
6 · The paper itself

Abstract

backgroundReported efficacy of platelet-rich plasma (PRP) in regenerative medicine is contradictory. We validated the effects of PRP on proliferation of canine bone marrow-derived multipotent mesenchymal stromal cells (K9BMMSCs) in vitro. PRP was extracted from blood of six dogs with osteoarthritis. K9BMMSCs were established from bone marrow and characterized for CD90 and CD19 expression by immunocytochemistry. Effects of PRP concentrations on viability of matching autologous K9BMMSCs were validated using MTS assay.

resultsPositive CD90 and negative CD19 expression confirmed MSC origin. PRP at 40% volume/volume concentration increased, while PRP at 80 and 100% v/v concentrations suppressed viability of tested K9BMMSCs.

conclusionPRP concentration plays an important role in K9BMMSCs viability, which could affect tissue repairs in vivo.

Indexed as

Cell ProliferationAnimalsAntigens, CD19Bone Marrow CellsCells, CulturedCell SurvivalDogsGene Expression ProfilingGene Expression RegulationMesenchymal Stem CellsPlatelet-Rich PlasmaThy-1 AntigensAntigens, CD19Thy-1 AntigensBone marrowCanineCell viabilityMultipotent mesenchymal stromal cellsOsteoarthritisPlatelet-rich plasmaRegenerative medicine

Identifiers

PMID31362739
PMCPMC6668135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.